ARCHITECT Toxo IgG
Enzyme Linked Immunoabsorbent Assay, Toxoplasma Gondii. 510(k) K210596, from Abbott Laboratories (Abbott Park, IL). Product code LGD, class 2.
As of Nov 21, 2026, K210596 is an FDA 510(k) held by Abbott Laboratories, substantially equivalent on May 19, 2022 after 444 days, with no recalls tied to it in FDA's recall database.
- Review time: 444 days
- Recalls: 0
ARCHITECT Toxo IgG The ARCHITECT Toxo IgG assay is a chemiluminescent microparticle immunoassay (CMIA) used for the quantitative determination of IgG antibodies to Toxoplasma gondii in human serum and plasma on the ARCHITECT i System.
- Vidas Toxo Igg Ii (Txg) Assay Model 30 210K993319 · bioMerieux, Inc. · May 22, 2000
- Access Toxo IgGK242022 · Beckman Coulter, Inc. · Mar 28, 2025
- Access Toxo IgM IIK242095 · Beckman Coulter, Inc. · Oct 11, 2024
- Alinity i Toxo IgMK233932 · Abbott Laboratories · Aug 30, 2024
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Mar 1, 2021
- Review panel
- Microbiology
- Regulation
- 21 CFR 866.3780
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files